Palo Alto Investors Increased Its Acadia Pharmaceuticals (ACAD) Position; FMC (FMC) Covered By 18 Bullish Analysts Last Week

October 12, 2017 - By test

Among 29 analysts covering FMC Tech (NYSE:FMC), 18 have Buy rating, 1 Sell and 10 Hold. Therefore 62% are positive. FMC Tech had 70 analyst reports since July 23, 2015 according to SRatingsIntel. Goldman Sachs upgraded the shares of FMC in report on Monday, December 12 to “Buy” rating. On Thursday, July 23 the stock rating was maintained by Cowen & Co with “Outperform”. The stock has “Neutral” rating by Longbow on Friday, August 28. Jefferies upgraded the stock to “Buy” rating in Wednesday, September 23 report. The stock has “Neutral” rating by Citigroup on Friday, July 15. The firm has “Market Perform” rating by BMO Capital Markets given on Thursday, August 3. On Monday, April 3 the stock rating was upgraded by Suntrust Robinson to “Buy”. Credit Suisse maintained the stock with “Buy” rating in Friday, May 5 report. CLSA initiated FMC Corp (NYSE:FMC) on Friday, April 15 with “Outperform” rating. The stock has “Outperform” rating by Credit Suisse on Friday, November 4. See FMC Corp (NYSE:FMC) latest ratings:

09/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $93.0 Maintain
06/10/2017 Broker: Piper Jaffray Rating: Hold New Target: $85.0 Maintain
29/09/2017 Broker: Loop Capital Rating: Buy New Target: $102 Initiates Coverage On
15/09/2017 Broker: Jefferies Rating: Buy New Target: $100.0 Maintain
11/09/2017 Broker: Robert W. Baird Rating: Hold New Target: $86.0 Maintain
08/09/2017 Broker: BMO Capital Markets Rating: Hold New Target: $80.0 Maintain
05/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $93.0 Maintain
04/09/2017 Broker: Piper Jaffray Rating: Hold New Target: $85.0 Maintain
31/08/2017 Broker: Bank of America Old Rating: Underperform New Rating: Buy Upgrade
14/08/2017 Broker: Jefferies Rating: Buy New Target: $100.0000 Maintain

Palo Alto Investors Llc increased Acadia Pharmaceuticals Inc (ACAD) stake by 1.44% reported in 2017Q2 SEC filing. Palo Alto Investors Llc acquired 22,900 shares as Acadia Pharmaceuticals Inc (ACAD)’s stock declined 29.10%. The Palo Alto Investors Llc holds 1.61 million shares with $45.00M value, up from 1.59 million last quarter. Acadia Pharmaceuticals Inc now has $4.38 billion valuation. The stock rose 0.11% or $0.04 reaching $35.8 per share. About 353,861 shares traded. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 15.19% since October 12, 2016 and is downtrending. It has underperformed by 31.89% the S&P500.

Investors sentiment decreased to 0.91 in Q2 2017. Its down 0.39, from 1.3 in 2017Q1. It worsened, as 60 investors sold FMC Corp shares while 163 reduced holdings. 77 funds opened positions while 125 raised stakes. 118.92 million shares or 1.89% more from 116.71 million shares in 2017Q1 were reported. Carroll Financial Associate holds 0.01% of its portfolio in FMC Corp (NYSE:FMC) for 1,057 shares. Exxonmobil Invest Mngmt Tx invested 0.05% in FMC Corp (NYSE:FMC). Point72 Asset Mngmt Lp accumulated 201,360 shares. Bluecrest Capital Limited accumulated 34,475 shares or 0.1% of the stock. Rhumbline Advisers reported 0.04% in FMC Corp (NYSE:FMC). 7,420 were accumulated by Moors & Cabot. Mesirow Management reported 20,440 shares. Salem Inv Counselors has invested 0% of its portfolio in FMC Corp (NYSE:FMC). Pitcairn reported 0.04% of its portfolio in FMC Corp (NYSE:FMC). Moreover, Norman Fields Gottscho Management Ltd Liability Corp has 0.15% invested in FMC Corp (NYSE:FMC). Raymond James Associate has invested 0.02% in FMC Corp (NYSE:FMC). Btg Pactual Global Asset Management holds 104,305 shares or 2.21% of its portfolio. Barclays Public Lc owns 0.01% invested in FMC Corp (NYSE:FMC) for 133,734 shares. Brinker Capital owns 17,861 shares. Clinton Group Inc holds 4,776 shares.

About 252,933 shares traded. FMC Corp (NYSE:FMC) has risen 62.57% since October 12, 2016 and is uptrending. It has outperformed by 45.87% the S&P500.

Since May 12, 2017, it had 0 insider buys, and 5 sales for $3.50 million activity. Norris Eric sold 11,358 shares worth $860,339. $218,196 worth of stock was sold by Powell William Howard on Friday, May 12. 14,434 shares valued at $1.08M were sold by UTECHT ANDREA E on Monday, May 15. On Wednesday, June 14 DOUGLAS MARK sold $962,626 worth of FMC Corp (NYSE:FMC) or 12,697 shares.

FMC Corporation is a diversified chemical firm serving agricultural, consumer and industrial markets. The company has market cap of $12.59 billion. The Firm operates in three business divisions: FMC Agricultural Solutions, FMC Health and Nutrition, and FMC Lithium. It has a 59.7 P/E ratio. As of December 31, 2016, the FMC Agricultural Solutions segment developed, marketed and sold three classes of crop protection chemicals: insecticides, herbicides and fungicides.

Among 12 analysts covering ACADIA Pharmaceuticals (NASDAQ:ACAD), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. ACADIA Pharmaceuticals had 28 analyst reports since August 7, 2015 according to SRatingsIntel. Jefferies maintained it with “Buy” rating and $47.0 target in Monday, September 4 report. H.C. Wainwright maintained the shares of ACAD in report on Thursday, October 5 with “Buy” rating. On Friday, August 7 the stock rating was downgraded by Piper Jaffray to “Overweight”. Ladenburg Thalmann reinitiated ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on Thursday, February 2 with “Buy” rating. The firm earned “Buy” rating on Thursday, October 5 by Piper Jaffray. Roth Capital reinitiated the stock with “Neutral” rating in Wednesday, October 19 report. The stock has “Neutral” rating by Piper Jaffray on Thursday, August 27. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has “Neutral” rating given on Friday, November 11 by Goldman Sachs. J.P. Morgan maintained it with “Buy” rating and $50.0 target in Thursday, October 5 report. The rating was maintained by Cowen & Co on Wednesday, August 9 with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com